The first dry spot represents the earliest visible loss of a continuous tear-film surface after blinking. Because the tear film normally helps maintain a smooth, protective ocular surface, this endpoint provides a practical indicator of how long that surface remains intact. An earlier dry spot therefore signals greater tear-film instability.
A complete blink establishes the starting point for the interval being measured. The clinician then observes the ocular surface until the first dry spot appears, creating a defined relationship between surface renewal and visible tear-film disruption. This timing approach allows the test to assess stability during the period between blinks.
A shorter interval indicates that the tear film becomes visibly unstable sooner. This finding can support evaluation of dry eye disease and other ocular-surface disorders, particularly when clinicians relate the measurement to a patient’s symptoms. The result provides information about tear-film dysfunction rather than simply describing the presence of ocular discomfort.
Tear Break-up Time helps clinicians relate reported symptoms to an observable feature of ocular-surface function. When symptoms occur alongside reduced tear-film stability, the measurement can support an assessment of tear-film dysfunction. This connection is useful because it links the patient’s experience with a measurable change seen during clinical examination.
The examination begins with placement of fluorescein dye on the ocular surface. Using a slit lamp, the clinician observes the eye after a complete blink and measures the interval until the first dry spot appears. The recorded time supplies the clinical measure used to judge tear-film stability.
The procedure requires fluorescein dye to make changes on the ocular surface visible and a slit lamp for observation. The clinician also needs a way to measure the interval between the complete blink and the first dry spot. Together, these components support a rapid assessment of tear-film behavior in the eye.
Clinicians use the measurement when evaluating dry eye disease and other ocular-surface disorders. It is especially useful when the goal is to connect symptoms with tear-film dysfunction or to examine whether tear-film stability changes during treatment. Its rapid and minimally invasive nature supports use in routine ophthalmic practice.
In ophthalmic research and clinical care, the measurement provides a way to assess tear-film stability at a given examination and to evaluate changes during treatment. Comparing the observed interval across assessments can help show whether tear-film behavior has changed, while still keeping the focus on ocular-surface function and patient symptoms.